Informed decision making for this older women regarding breast cancer screening should be a public health priority.
Providing older women with necessary information in order to make an informed decision regarding breast cancer screening should be a priority, according to an article in the International Journal of Radiation Biology.
Researchers from Australia sought to determine the benefits and harms of biennial breast cancer screening for women aged 70 to 74. The Australian national breast cancer screening program had gradually invited women in this age group to attend screening, and the researchers evaluated the benefits and harms of the screening. They calculated the estimates of relative risk reduction of breast cancer mortality and the risk of overdiagnosis using measures taken from the Independent U.K. Panel on Breast Cancer Screening.
The researchers estimated screening specific outcomes (recalls for further imaging, biopsies, false positives, and interval cancer rates) from data published by BreastScreen Australia.
The results showed that when compared with stopping screening at age 69, screening 1,000 women to age 74 was likely to avert one more breast cancer death, with an additional 78 women receiving a false positive result and another 28 women diagnosed with breast cancer, of whom eight will be overdiagnosed and overtreated.
The extra five years of screening results in approximately seven more overdiagnosed cancers to avert one more breast cancer death. The researchers concluded that by extending screening mammography in Australia to older women, there was less favorable harm to benefit ratio than stopping at age 69. They suggested that supporting informed decision making for this age group should be a public health priority.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
What a New Study Reveals About Adjunctive DBT and Early-Stage Invasive Breast Cancer
December 6th 2023The combination of digital breast tomosynthesis (DBT) and digital mammography had a 21.6 higher invasive breast cancer detection rate for stage 1 tumors than digital mammography alone, according to a new study involving nearly 100,000 women.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.
Study Says Contrast-Enhanced Mammography Offers Comparable Breast Cancer Detection to MRI
November 15th 2023In findings from an enriched cohort of asymptomatic patients with screening-detected abnormalities, researchers found that contrast-enhanced mammography (CEM) was superior to conventional mammography and offered equivalent detection of breast cancer in comparison to breast MRI and abbreviated breast MRI.